USSTOCK.TODAY
Market Closed
Log in Sign up

Dr. Reddy's Laboratories Limited reports $905 million in consolidated revenue for Q2 FY27

The Motley Fool +1 ·

RDY
RDY Dr. Reddy's Laboratories Ltd ADR
$13.21 -0.15%
View chart & analysis →
  1. 1Dr. Reddy's Laboratories Limited reported a 1.5% year-over-year decrease in revenue.
  2. 2Dr. Reddy's Laboratories Limited recorded an EBITDA margin of 20.6% for the quarter.
  3. 3Dr. Reddy's Laboratories Limited Global Generics reported a gross margin of 56.2% for Q2 FY27.

So what's the key point?

Dr. Reddy's Laboratories Limited's revenue decreased by 1.5% compared to last year. This shows the proportion of profit out of the total money the company earned.

Source The Motley Fool +1 · View original ↗

Related 3-line summaries

TPG RE Finance Trust (TRTX) to report Q2 results on the 28th GuruFocus.com +1 · Jul 28AT&T reports strong earnings and raises 2026 adjusted EPS guidance amid SpaceX threats The Motley Fool +1 · 1h agoSL Green Realty Corp. Reports $1.59 Per Share FFO for Q3 and Raises 2026 Annual FFO Guidance Earnings Whispers +1 · 1h ago
Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →
← Back to news